The process involving the use of small, non-peptidic molecules designed to mimic the biological activity and receptor interaction profile of natural peptide hormones, such as growth hormone secretagogues or GLP-1 analogs. These compounds offer advantages in oral bioavailability and resistance to enzymatic degradation compared to native peptides. They are synthetic tools used to modulate specific endocrine axes.
Origin
The term is a portmanteau of ‘peptide’ and ‘mimetic,’ meaning ‘imitating.’ This synthetic chemistry approach aims to create orally active drugs that retain the specificity of peptide hormones, which are otherwise poorly absorbed. It represents an advancement in endocrine pharmacology.
Mechanism
Peptidomimetics function by binding to the cognate peptide receptor with high affinity, activating the receptor’s intracellular signaling cascade in a manner similar to the natural ligand. This often involves mimicking the key residues responsible for receptor contact while utilizing a more stable chemical scaffold. Successful signaling requires that the mimetic achieves sufficient tissue concentration and maintains the correct conformational lock on the receptor.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.